Establishment and evaluation of cell and animal models expressing BORIS subfamily 2 variant

BACKGROUND: The possibility of a cancer vaccine aimed at stimulating or mobilizing the body’s immune system to control and kill tumor cells is emerging as a potential new strategy for tumor immunological therapy. CCCTC-binding Factor Like (CTCFL)/Brother of the Regulator of Imprinted Sites (BORIS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Lu, Liu, Zhong-Jian, Xian, Long-Jun, Hu, Lei, Fu, Qiang, Chen, Li-Hong, Qin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263788/
https://www.ncbi.nlm.nih.gov/pubmed/35813346
http://dx.doi.org/10.21037/atm-21-6336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263788/
https://www.ncbi.nlm.nih.gov/pubmed/35813346
http://dx.doi.org/10.21037/atm-21-6336

Ejemplares similares